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notion at the time, one that challenged existing concepts
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New Haven, Connecticut 06520 of Susumu Tonegawa in the 1970s (Tonegawa et al.,
1977). Based on this work, and its many subsequent
refinements, it is now known that the antigen receptors
of B and T lymphocytes are encoded by genes that areIntroduction
produced by somatic recombination of gene segmentsImmunology is the study of the body's defenses against
during maturation of the cells. The recombination pro-infection. The birth of immunology as an experimental
cess is initiated by the RAG proteins, and presence ofscience dates to Edward Jenner's successful vaccina-
RAG genes during phylogeny identifies the evolutionarytion against smallpox in 1796 (Jenner, 1798). The world-
time of appearance of the adaptive immune system,wide acceptance of vaccination led to mankind's great-
which is just past the appearance of vertebrates (Agra-est achievements in preventing disease, and smallpox
wal et al., 1998; Hiom et al., 1998). The jawless fish lackis the first and only human disease that has been eradi-
RAG genes and lymphoid organs, while cartilaginouscated. During the twentieth century, the impact of immu-
fish have RAG genes and a quite well-developed adap-nology has moved beyond defense against infections.
tive immune system. Recombination of antigen receptorOur growing understanding of the immune system has
gene segments serves three critical functions: it allowsinfluenced a variety of different biomedical disciplines
a vast number of receptors to be generated from a smalland has played an important role in the study and treat-
number of genes, it maximizes the diversity of the recep-ment of many human diseases (Abbas et al., 1997; Jane-
tors by introducing sequence variations at the sites ofway et al., 1999; Paul, 1999). However, it is still clear
recombination, and it regulates the development of indi-that the primary role of the immune system is resistance
vidual lymphocytes, which is tightly linked to the statusto infection. In this review we survey the evolution of
of gene rearrangement. Somatic recombination of anti-immunology as a scientific discipline and speculate on
gen receptor genes is the paradigm for studying genesome of the directions in which the field is likely to move
rearrangement during cell maturation.in the future. Among these, we hope that it will become
Immunological Memorypossible to use manipulation of the adaptive immune
Immunological memory refers to the ability of the im-response to overcome many human diseases. These
mune system to respond more strongly to successiveare currently treated only with drugs that do not exploit
exposures to the same antigen. The classical definitionthe specificity of adaptive immunity. We also point out
of memory came from the realization that infection with asome of the areas in which studying the immune system
particular microbe or vaccination rendered an individualhas led to the discovery of principles with broad implica-
resistant to subsequent exposures to that microbe; thattions for diverse biological processes.
is, they were immune to the specific pathogen. Much
effort has been devoted to defining the phenotypic andThe Basis for Specificity and Memory in Adaptive
functional characteristics of memory cells, and muchImmune Responses
has been learned about what these cells do. However,The earliest studies of protective immunity against infec-
fundamental questions about the signals that are re-tions established the two defining characteristics of
quired to generate memory cells, and the mechanismsadaptive immunity, namely, specificity for the antigenic
responsible for the survival of these cells in the apparentdeterminants of pathogens, and the memory of having
absence of antigen, remain unsolved. This uncertaintybeen exposed to the same pathogen previously, called
is mainly a reflection of the fact that immunologicalimmunological memory. Implicit in the phenomenon of
memory has to be studied in vivo, and only recentlyspecificity is the concept of the enormous diversity of
have methods been developed to identify numericallythe receptor repertoires of lymphocytes.
rare antigen-specific populations in the midst of largeSpecificity and Diversity
numbers of lymphocytes with diverse specificities (Alt-The specificity of immune responses was initially in-
man et al., 1996; Murali-Krishna et al., 1998; Ogg et al.,ferred from studies of protective immunity and vaccina-
1998).tion against microbes, which was by definition pathogen
specific. These early studies culminated in the formula-
tion of the clonal selection hypothesis in the 1950s, The Initiation of Immune Responses:
What Lymphocytes Seewhich proposed that clones of immunocompetent cells
with unique receptors exist prior to exposure to anti- The key breakthrough that opened the way for our mod-
ern understanding of the immune system was the identi-gens, and only cells with specific receptors are selected
by antigen for subsequent activation (Figure 1) (Burnet, fication by Jim Gowans of small lymphocytes as the
cellular units of clonal selection in adaptive immunity1959). The idea that specificity for diverse antigens ex-
ists prior to encounter with these antigens was a radical (Gowans et al., 1962). We now know that there are two
Cell
130
Figure 1. The Clonal Selection Theory of
Lymphocytes
Schematic of clonal selection hypothesis il-
lustrating the idea that each naõÈve lympho-
cyte has a different receptor specificity, each
of which can bind a different antigenic deter-
minant. When a pathogen is recognized by
the cells, in this case by two different anti-
genic determinants, then the cells that bind to
these determinants are selected to proliferate
or undergo clonal expansion, and then differ-
entiate into effector cells that either secrete
antibody or mediate various effector mecha-
nisms of cell-mediated immunity.
classes of antigen-specific lymphocytes with receptors bound to one of that individual's 5±15 MHC allelic prod-
ucts (Babbitt et al., 1985). As there are over 100 allelesfor antigens, B and T cells, which function as the media-
tors of humoral immunity and cell-mediated immunity, at several loci within the MHC, this means that the MHC
is the most polymorphic set of loci within the humanrespectively. The use of monoclonal antibodies (Kohler
and Milstein, 1975) to identify different populations of genome.
The dual specificity of T cells, for peptide antigenslymphocytes and to isolate these populations for func-
tional and biochemical analyses has been instrumental and for MHC molecules, led to many theories about how
T cells recognized antigens. The great controversy wasin understanding lymphocyte biology. In fact, the ease
of producing fairly homogeneous populations of lym- whether T cells expressed a single receptor that saw
both peptide and MHC, or one receptor for each. Earlyphocytes with defined specificitiesÐby purification, cell
cloning, and transgenic technologyÐis the principal studies showed that fusing two distinct T cell lines did
not generate four different specificities, as predicted byreason why lymphocytes have taught us a great deal
about fundamental biological phenomena. the dual specificity model, but rather the two original
specificities of the parent clones, as would be predictedOne of the most impressive accomplishments of im-
munology is the elucidation of antigen recognition by from the single receptor hypothesis (Kappler et al.,
1981). Biochemical analyses of the T cell antigen recep-lymphocytes. We now know that B cell antigen receptors
bind a wide variety of macromolecules and small chemi- tor also showed a single receptor molecule, but the
identification of the T cell receptor (TCR) for antigencals in different conformations. However, the greatest
surprises have come from studies of T cell antigen rec- came from molecular cloning (Hedrick et al., 1984). The
definitive results that established the structural basis ofognition. This story began with the discovery, in the
1960s and 1970s, that different inbred strains of animals MHC restriction came with the solution of the crystal
structure of MHC molecules, which showed that thesedid or did not respond to simple polypeptide antigens,
and this immune responsiveness mapped to a highly molecules contained bound peptides (Bjorkman et al.,
1987) (Figure 2), and ultimately in the solution of thepolymorphic genetic locus that had been discovered as
the target of graft rejection and was therefore called crystal structures of T cell receptors binding to MHC:
peptide complexes (Figure 2) (Garboczi et al., 1996; Gar-the major histocompatibility complex (MHC) (Benacerraf
and McDevitt, 1972). These phenomena eluded explana- cia et al., 1996). These remain among the most informa-
tive crystal structures ever defined because they re-tion until, in the mid-1970s, Zinkernagel and Doherty
found rather serendipitously that virus-specific CTLs vealed in fine detail the basis for one of the puzzling
features of antigen recognition. A great surprise fromgenerated in one inbred mouse strain would kill virus-
infected target cells only from strains with the same these structural results, which confirm previous data
based on mutational analyses of peptides, is that eachMHC (Zinkernagel and Doherty, 1974). This observation,
and the results of experiments examining the interac- TCR recognizes very few residues of the MHC-associ-
ated peptide. Taken together with the established ideations of T cells with either B lymphocytes (Katz et al.,
1973) or macrophages (Rosenthal and Shevach, 1973), that even in complex microbes, only a few peptides are
recognized by the immune system, this means that Tultimately led to the conclusion that in each individual
or inbred strain of mouse, T lymphocytes are limited to cells are able to distinguish between different microbes
on the basis of very few differences in amino acid se-recognizing foreign protein antigens on the surface of
that individual's or strain's own cells, and the key ele- quences. How this remarkable specificity is maintained
despite the enormous structural diversity of microbesment in antigen recognition by T cells is the MHC. This
ability to recognize antigen only in the context of self- remains a fascinating question.
In parallel with these structural studies of the MHC,MHC molecules is called MHC restricted antigen recog-
nition, or MHC restriction for short. It is now known that cell biologists dissected the mechanisms of antigen up-
take, processing, and presentation. The key conclusionMHC molecules expressed on antigen-presenting cells
function to display peptides derived from complex pro- of these studies is that the two classes of MHC mole-
cules function to sample protein antigens from differentteins to T lymphocytes. Each individual T cell is selected
to recognize one or a small number of related peptides cellular compartments and display these antigens for
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The realizations that very few lymphocytes out of the
total population recognize any one antigen, very few
peptides derived from any microbe are recognized by
the immune system, and very few MHC molecules on
APCs display any one peptide have highlighted what
appears to be an insurmountable logistical problemÐ
how do we ever get effective immune responses against
microbes? This problem is largely handled by a special-
ized population of professional antigen-presenting cells
(APCs), the dendritic cells (DCs), which are strategically
located under the skin and the mucosal epitheliaÐ
common sites of contact with the external environment
(Banchereau and Steinman, 1998). Immature DCs are
highly phagocytic and are designed to capture microbial
antigens in the periphery. They then migrate to the T
cell±rich areas of local lymph nodes, where, as mature
DCs, they express high levels of MHC-associated pep-
tides derived from the pathogen. The migration is not aFigure 2. The Outline Structure to the T Cell Receptor Recognizing
a Cognate Peptide:MHC Class I Ligand random process and is tightly regulated by chemokines
The T cell receptor (TCR) binds to MHC:peptide complexes in a produced in the lymph nodes, for which dendritic cells
diagonal fashion as shown in the figure (Bjorkman, 1997). This has express specific receptors (Melchers et al., 1999). Once
been shown directly for several MHC class I:TCR cocrystals, and in the lymph node, DCs also begin to express molecules
indirectly for an MHC class II recognized by a TCR, in which all 6 that are necessary to activate the naõÈve T cells thatCDRs can be positioned diagonally over a MHC class II:peptide
continuously flow through the same areas of the lymphcomplex (Sant'Angelo et al., 1996).
node. Thus, the rare antigen-specific T cells come in
contact with antigen-loaded dendritic cells, leading to
the initiation of lymphocyte responses. Overall, ourrecognition by different classes of T cells. Protein anti-
present understanding of anitgen presentation to T lym-gens located in the cytosol are processed by prote-
phocytes provides one of the best examples of howasomes, translocated into the endoplasmic reticulum,
immunologists, biochemists, cell biologists, and mor-and displayed by MHC class I molecules for recognition
phologists can come together to attack a complex prob-by CD8 T cells. Thus, MHC class I molecules can alert
lem (Cresswell, 1994; Germain, 1994).CD8 T cells to the presence of foreign antigens, such
as viral and tumor antigens, that are synthesized within
Innate Immunityinfected or transformed cells, leading to the elimination
Innate immunity provides early host defense againstof these cells. By contrast, extracellular pathogens and
infections, before the development of an adaptive im-proteins that are internalized into the vesicles of phago-
mune response. Innate immune responses of marinecytes are processed by vesicular proteases and dis-
starfish were discovered by Elie Metchnikoff in the lateplayed bound to MHC class II molecules for recognition
1800s, and this work remains a cornerstone in the studyby CD4 T cells (Nakagawa et al., 1999). The elucidation
of various aspects of innate immunity (Metchnikoff,of the peptide display function of MHC molecules has
1893). Innate immunity is mediated by cells, such assolved two fundamental problems in immunology. The
phagocytes and natural killer cells, circulating proteins,first is how the immune system ensures that T cells,
such as the complement system, and numerous anti-designed to combat intracellular microbes, are the cells
microbial peptides. These components use germline-of cell-mediated immunity. The answer to this is that
encoded ªpattern recognition receptorsº to recognizebecause the MHC molecules that display peptides are
molecular structures, or ªpatterns,º present on variousintegral membrane proteins, T cells can only see anti-
classes of microbes. Many of these receptors, such asgens bound to other cells, and these are the antigens
the Toll family of proteins, are conserved throughoutof intracellular or phagocytosed microbes. The second
evolution and serve the same function of anti-microbialis how the immune system knows that it should make
defense in all multicellular organisms, including plants.antibodies against extracellular microbes but trigger the
Innate immunity also stimulates adaptive immune re-effector mechanisms of cell-mediated immunity, such
sponses (Medzhitov et al., 1997). This realization hasas T cell±mediated killing of infected cells, after mi-
explained some fundamental features of adaptive immu-crobes have found a haven inside host cells. This prob-
nity and is discussed in more detail below.lem was especially puzzling because humoral and cell-
mediated immune responses can be generated against
the same microbe, such as a virus, at different stages The Development of Immune Responses:
Lymphocyte Activationof its life, i.e., extracellular and intracellular, respectively.
The answer is that MHC molecules instruct the immune The survival and functional responses of lymphocytes
are regulated by cell±cell interactions and by an orches-system on how to respond by segregating the antigens
of vesicular and cytosolic antigens in such a way that trated interplay of positive and negative signals. All
adaptive immune responses are dependent on the acti-they are recognized by different classes of T cellsÐ
helper cells that stimulate antibody production and CTLs vation of antigen-specific lymphocytes, and this process
is triggered by binding of antigen to the lymphocytethat kill infected cells, respectively.
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Figure 3. The Two-Signal Theory of T Cell
Activation
When a T cell encounters an antigen present-
ing cell (APC) that expresses costimulatory
molecules but no foreign antigens, there is
no apparent signal (left panel); when a T cell
encounters a tissue cell or an APC that ex-
presses antigens recognized by the TCR in
the absence of costimulatory signals, the re-
sult is either no response or inactivation of
the cell (anergy). However, when a T cell en-
counters an activated dendritic cell or other
APC expressing both antigen and costimula-
tory molecules, then the T cell is activated to
proliferate and undergo differentiation to an
effector cell. Thus, T cells only become acti-
vated by their ligands when they are pre-
sented by a cell that expresses costimulatory
molecules.
receptors. To ensure that immune responses develop development of a new class of agents that inhibit im-
mune responses by blocking these signals. Antagonistsonly when they are needed, i.e., when there is an infec-
against B7 molecules and CD40 ligand are currently intion, naõÈve lymphocytes need at least two signals to be
clinical trials for inhibiting graft rejection and for treatingfully activated to proliferate and differentiate. The first
some hypersensitivity and autoimmune disorders (Foysignal is provided by specific antigen recognition. By
et al., 1996; Markees et al., 1998; Kenyon et al., 1999;itself, this signal can fail to stimulate a response or can
Kirk et al., 1999). The story is very much an evolvinginduce a state of inactivity referred to as clonal anergy,
one because new costimulators and their receptors con-the inability to respond to antigen (Schwartz, 1992) (Fig-
tinue to be discovered. What is needed is an integratedure 3). However, when the antigen is delivered as part
picture of when the individual costimulators are activeof a pathogen, the second signal is provided by innate
during immune responses, what types of responses theyimmune responses to microbes or, in some cases, by the
stimulate, and how they signal T cells.pathogen itself (Medzhitov et al., 1997). This requirement
Effector T cells can respond to antigen in the absencefor second signals explains why adaptive immune re-
of costimulators and thus are able to interact with manysponses are stimulated by microbes but not by most
cell types that express microbial antigens. They functionself-antigens, which are not normally recognized by the
by altering the behavior of their targets. MHC class I±innate immune system and therefore do not elicit adap-
restricted CD8 effector T cells can attack virtually anytive immune responses. Adjuvants are required to stimu-
cell in the body, as most cells express MHC class Ilate adaptive immune responses to protein antigens,
molecules. MHC class II±restricted CD4 T cells can onlyand the key constituents in these adjuvants are microbial
interact with cells that express MHC class II molecules,products, which function by stimulating innate immunity
such as macrophages carrying pathogens or B cells that(Janeway, 1989). The best defined second signals for T
bind specific antigens. The functions of effector T cellscells are the costimulatory molecules known as B7-1
are described in more detail later.(CD80) and B7-2 (CD86) (Harding et al., 1992; Linsley
The molecules that mediate cell±cell interactions areand Ledbetter, 1993). These molecules are only ex-
better defined in the immune system than in any other
pressed on professional APCs, and their expression
biological system (Dustin et al., 1998). This knowledge
peaks after the APCs are activated by microbial prod- has given immunologists valuable tools for analyzing the
ucts. Activated APCs also produce cytokines during in- processes of T cell±APC and T cell±B cell interactions in
nate immune reactions, which further stimulate T cell considerable detail. Recent studies have shown that
responses. The B7 proteins are recognized by the CD28 various surface molecules of T cells undergo rapid reori-
receptor, which is expressed on most naõÈve T cells, entation upon antigen recognition, with antigen recep-
especially those of the CD4 subset. Together with the tors and their associated signal-transducing subunits
antigen receptor signal (signal 1), recognition of B7 pro- aggregating in the central regions of membrane micro-
teins by CD28 leads to T cell activation, clonal expan- domains, and adhesion molecules forming peripheral
sion, and the development of effector T cell function rings around these clustered receptors (Dustin et al.,
(Figure 3). Activated T cells express a molecule called 1998; Monks et al., 1998). These molecular aggregates
CD40 ligand (CD40L), which has several functions. One have been called supramolecular activation complexes,
of these is to activate APCs to increase expression of B7 or immunological synapses, and some of them lie in
costimulators and to stimulate production of cytokines, lipid rafts on the cell surface. Presumably, aggregation
such as IL-12, that induce the differentiation of T cells. of antigen receptors brings sufficient receptor-associ-
Thus, CD40L serves to amplify T cell proliferation and ated signaling molecules into proximity to achieve the
differentiation into effector cells. The identification of threshold needed to trigger cellular responses. The sig-
naling molecules include a number of adapter proteins,second signals for lymphocyte activation has led to the
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kinases, and their substrates. How the receptors are chemokines, mentioned above as the signals for den-
aggregated in a particular topology upon binding to their dritic cell migration. Although chemokines were discov-
cognate ligand remains a mystery, and this issue is likely ered as mediators of leukocyte recruitment in inflamma-
to be one of interest to all biologists interested in the tion, it is now known that they control the normal traffic
problem of how cells sense and respond to other cells of lymphocytes, and other leukocytes, through tissues.
and external stimuli. Recent studies using the BIAcore T and B lymphocytes express receptors for different
suggest that T cell receptors change their shape upon chemokines, which are produced in different regions of
binding antigen and form aggregates on the cell surface lymphoid tissues and serve to keep the lymphocytes in
(Alam et al., 1999). The general rules of signal transduc- place. Activation and differentiation of the lymphocytes
tion in lymphocytes are probably fundamentally similar changes the expression of chemokine receptors, allowing
to those in other cells, using common response path- the cells to leave their normal residence and migrate to
ways such as increases in intracellular calcium, activa- regions where they can interact with other cells (Sallusto
tion of kinase cascades, and activation of the mitogen and Lanzavecchia, 1999). The elucidation of these roles
activated kinases (Weiss and Littman, 1994). The culmi- of chemokines, and of the regulation of chemokine re-
nation of these signaling cascades is translocation of ceptors on lymphocytes that are associated with their
activated transcription factors into the cell nucleus, re- differentiation, are some of the most exciting recent
sulting in the expression of genes that encode cytokines, developments in immunology. The fact that chemokine
cytokine receptors, and cell cycle regulators, all of which receptors also play an essential role in the process of
are necessary for clonal expansion. infection with HIV, the causative agent of the AIDS, only
In response to antigen recognition, second signals, serves to add fuel to the interest in these molecules and
and cytokines, lymphocytes proliferate and differentiate their receptors (Huang et al., 1996; Berger et al., 1999).
into effector cells. Recent analyses of the numbers of The function of chemokines in the immune system has
antigen-specific CD8 T cells, performed using tetrava- led to studies revealing equally important roles of these
lent complexes of MHC molecules loaded with antigenic proteins in the development of other organs and the con-
peptides as staining reagents, have revealed a remark- trolled migration of cells even in nonlymphoid tissues.
able and unexpected level of clonal expansion in acute Because immune responses have the potential to
microbial infections (Altman et al., 1996; Murali-Krishna cause injury to host tissues, it is not surprising that they
et al., 1998). From a preimmunization level of 1 in 105 T are tightly controlled. It is now clear that lymphocytes
cells specific for a particular microbial antigenic peptide, express receptors capable of delivering both positive
the frequency can increase to almost 1 in 3 within a and negative signals. We have mentioned previously
few days of infection, and the total number of antigen- that CD28 on T cells recognizes B7 molecules on APCs
specific T cells can increase by almost 100,000-fold in and is involved in T cell activation. Activated T cells
this time, with virtually no change in the numbers of express another receptor called CTLA-4 (CD152), which
lymphocytes that are not specific for the microbe. Based also recognizes the same B7 molecules but shuts off
on such results, the doubling time of antigen-stimulated responses by inhibiting TCR and CD28-mediated sig-
CD8 T cells is estimated to be z6 hours. The clonal nals (Lee et al., 1998). B lymphocytes respond to antigen
expansion of antigen-specific CD4 helper T cells might recognition by their antigen receptors and express re-
be less, in the order of 100- to 1,000-fold, and the magni- ceptors that recognize the Fc portions of antigen com-
tude of B cell expansion during immune responses in plexed with antibody to shut off B cell activation once
vivo has not yet been defined. A fraction of this ex- enough antibody is produced. Natural killer cells are
panded pool of lymphocytes differentiates into effector activated to kill virus-infected cells using a number of
cellsÐantibody secreting cells (from B lymphocytes), receptors, but are prevented from killing uninfected host
cytokine-producing helper T cells, and cytotoxic T lym- cells by inhibitory receptors that recognize class I MHC
phocytes, some of which can be long-lived. After immu-
molecules of the host. One of the most interesting ques-
nization or infection, plasma cells producing specific
tions in immunology is how the balance between these
antibodies can be found in the bone marrow years later,
opposing signals is adjusted to keep the system at restand the antibodies they produce presumably continue
normally, to enable it to respond rapidly to encountersto provide rapid protection against a repeated infection
with pathogens, and to return it to its basal resting statewith the same pathogen. As the antigen is eliminated and
as the pathogen is eliminated.the adaptive immune response subsides, the antigen-
specific lymphocytes are deprived of survival stimuli
The Immune System Uses Diverse Effectorand the majority die by apoptosis. At the end of the
Mechanisms to Eliminate Differentactive response, the only survivors are some long-lived
Types of Microbeseffector cells and memory lymphocytes.
The immune system has to protect the host from anGiven the complexities of cell±cell interactions in im-
almost unlimited diversity of microbes. This is achievedmune responses and the easy mobility of lymphocytes
by building into the system a large potential for special-and other cells of the immune system, it has been a
ization, which ensures that the system responds appro-mystery how these interactions are controlled with pre-
priately to each type of microbe in a way that optimizescision. A clue that intercellular communication must be
elimination of that particular microbe. B lymphocytesregulated in some way was suggested by the old mor-
recognize and respond to extracellular microbes andphological observation that in lymphoid tissues, T and
their toxins, produce antibodies that neutralize theseB lymphocytes are segregated in distinct anatomic com-
microbes and toxins, and promote their elimination bypartments. We now know that this segregation is main-
tained in large part by the family of cytokines called phagocytes. They do so mainly under the direction of
Cell
134
Figure 4. The Three Well-Defined Effector Functions of Lymphocytes
There are three types of well-characterized effector T cells. The CD8 effector T cells are primarily reactive against intracellular pathogens
such as viruses and bacteria that live in the cytosol. CD4 Th1 cells are reactive to intracellular pathogens, or to pathogens that have been
ingested by a phagocyte, whereupon they release interferon g, which activates strong antimicrobial activity in the macrophage; Th1 cells also
activate B cells making antibody that promotes phagocytosis of the pathogen. CD41 Th2 cells activate B cells to produce nonphagocytic
antibodies, including IgE, and also activate nonphagocytic leukocytes, mainly eosinophils; Th2 cells are especially strongly activated by
parasitic worm infection, which induces high levels of IgE and eosinophilia. The activated eosinophils express a surface receptor for IgE and
can attack the parasitic worms coated with IgE.
helper T lymphocytes, which activate B lymphocytes to As adaptive immunity has become increasingly spe-
make antibodies and activate phagocytes to eliminate cialized and sophisticated, microbes have evolved new
microbes that grow within intracellular vesicles or that ways to fight back. The ability of viruses, bacteria, and
are ingested from the extracellular environment. other microbes to evade host immunity by altering their
An important discovery, with many physiological and major antigens is well recognized. Many viruses inhibit
pathological implications, has been the finding that acti- pathways of antigen processing and presentation in in-
vated helper T cells exist in specialized subsets that fected cells and are thus able to hide from T cells. For
perform distinct functions by producing distinct sets of instance, some viruses interfere with the biosynthesis
cytokines (Kim et al., 1985; Mosmann et al., 1986). In or assembly of MHC class I molecules, so that infected
response to phagocytosed and intracellular microbes, cells do not express the MHC class I:peptide complexes
helper T cells differentiate into the Th1 subset, which that are needed to stimulate CD8 T lymphocytes
produces cytokines (principally IFN-g) that activate (Ploegh, 1998). The specificity of natural killer cells might
phagocytes to destroy the infectious agent. In striking be an adaptation against these viral evasion mecha-
contrast, helminths induce the differentiation of helper nisms because natural killer cells are activated by in-
T cells into Th2 cells, whose cytokines (IL-4 and IL-5) fected cells that specifically lack one or more MHC class
induce IgE and eosinophil-mediated destruction of the I molecules (Ljunggren and Karre, 1990; Yokoyama and
pathogens (Figure 4). These subsets also play distinct Seaman, 1993). This is an elegant example of the con-
roles in diseases, with Th1 cells being involved in most stant evolutionary struggle between microbes and hosts,
inflammatory autoimmune diseases and Th2 cells in al- with each adapting to the other. Other viruses, such as
lergic disorders mediated in part by IgE. The existence HIV, evade immunity by infecting and destroying the T
of T cell subsets has become one of the dominant lymphocytes themselves.
themes of immunology, and an enormous effort is being
devoted to elucidating the biological and molecular ba-
The Selection of Immune Receptor Repertoiressis of CD4 T cell differentiation into these subsets. Cyto-
and Their Maintenance in the Peripherytoxic T lymphocytes function mainly to kill cells harbor-
The generation of highly diverse repertoires of antigening microbes whose antigens enter the cytosol, such as
receptors by somatic recombination of receptor geneviruses and some intracellular bacteria, and thus elimi-
nate the reservoirs of infection (Figure 4). segments has an intrinsic flaw, which is that the same
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process produces receptors that are either of no use to in the absence of adequate costimulation (Schwartz,
1992), and apoptotic cell death, which results from re-the individual or, worse, actually harmful to the individual
because they recognize self-antigens and may cause peated stimulation by persistent self-antigens (Zuniga-
Pflucker et al., 1995). Less is known about mechanismsautoimmunity. This potential problem is largely cor-
rected by selection processes that eliminate both use- of peripheral B cell tolerance. Failure of self-tolerance
can eventually result in the development of autoimmuneless and harmful lymphocytes before the cells mature
to a stage of functional competence. The processes of diseases, which are among the most common and enig-
matic of immunological diseases (Rose and Mackay,repertoire selection are best defined in T lymphocytes.
During their maturation in the thymus, immature T lym- 1998). There is great hope that animal models and geno-
mic approaches will provide valuable clues about thephocytes that recognize self-peptides complexed to
self-MHC molecules are positively selected to survive genetic basis and pathogenesis of autoimmune dis-
eases. Many gene knockout or mutant mouse strains(von Boehmer, 1994). This process of positive selection
preserves only T cells that can see self-MHC-bound develop what looks like autoimmunity. The best studied
of these genes are involved in anergy or activation-antigens in the periphery because these antigens will be
displayed by the self-MHC molecules in each individual. induced apoptosis, which suggests that defects in these
genes cause autoimmunity by disrupting one or more ofAlso in the thymus, T cells that recognize self-MHC:self-
peptide complexes with high affinity are deleted from the mechanisms of peripheral self-tolerance (Van Parijs
and Abbas, 1998). It remains to be seen how much thesethe repertoire by apoptosis (Nossal, 1994). This process
of negative selection is also called central tolerance animal models will teach us about human autoimmune
diseases. One example of this is the so-called autoim-because it is the form of tolerance that is induced in the
central or generative lymphoid organ. The factors that mune disease accompanied by lymphoproliferation seen
in mice and humans with mutations in CD95 (Fas). Indetermine whether a particular clone of T cells with
receptors of one specificity will be selected positively such people, the phenotype is often seen with just one
chromosome mutated, perhaps because CD95 is ex-or negatively, or simply be neglected to die, are not yet
well understood. Similar selection processes in the bone pressed as a trimer on the cell surface, such that a single
mutant protein subunit needs to be defective in ordermarrow appear to shape the repertoire of mature B lym-
phocytes. Once T and B cells leave the central lymphoid to prevent normal CD95 function.
organs and enter the periphery, there is evidence that
further contact with the positively selecting ligand main- Summary: Where We Have Been and Where
tains their numbers and also their sensitivity to activa- We Are Heading
tion. In T cells, this has been shown using mice that The impressive advances in immunology are largely a
lack the selecting ligand as a result of genetic deletion. triumph of reductionist approaches. Our ability to isolate
Mice that lack MHC class I molecules do not allow trans- and analyze pure and homogenous populations of T and
ferred CD8 T cells to survive (Tanchot et al., 1997; Gold- B lymphocytes is one reason we know more about the
rath and Bevan, 1999), while mice that lack MHC class proteins and genes of lymphocytes than about any other
II molecules do not allow CD4 T cells to survive (Ernst cell type in mammals. Lymphocytes have also served
et al., 1999; Viret et al., 1999). Mature B cells that have as the models for identifying many genes, receptors,
their B cell antigen receptors removed also die rapidly signal transduction mechanisms, and other processes
that are relevant to virtually all biological systems. It has(Lam et al., 1997). All these findings are consistent with
the hypothesis that ongoing interactions with self-ligands been only forty years since the function of lymphocytes
as the cellular mediators of adaptive immunity was es-in the peripheral lymphoid tissues are required to ensure
the survival of the cells of the adaptive immune system. tablished by Gowans. In this brief period, the signals
and controls operative in lymphocyte function have beenThese findings again highlight how the consequences
of antigen recognition by lymphocytes are tightly con- described in reasonable detail using these reductionist
approaches. The greatest gaps in our knowledge are introlled. Thus, positively selected mature but naõÈve lym-
phocytes normally recognize some endogenous self- the areas where reductionist approaches fail. For in-
stance, we know relatively little about the developmentantigens well enough to stay alive but not so well that
they are activated. When a microbial antigen is intro- of adaptive immune responses in vivo, and even less
about the largely neglected area of innate immunity,duced, some of the same lymphocytes receive signals
that are strong enough to initiate the activation process. particularly its role in inducing the interplay between
innate and adaptive immunity. We also do not under-This, of course, might be partly attributable to the fact
that normally, the absence of infection and innate immu- stand how different signals are integrated in lymphocytes,
especially during physiological immune responses, againnity prevents lymphocyte activation. However, this is
unlikely to be the full answer because an active response because such responses usually have to be studied in
vivo, where the multiple interactions involved are diffi-to one microbe accompanied by innate immunity does
not result in bystander activation of other lymphocytes cult to dissect. The next wave of basic research in immu-
nology is likely to focus on immune responses in intactthat do not recognize their cognate antigensÐeven
though these lymphocytes are being kept alive all the organisms, both experimental animals and humans.
Several technical advances are making such studiestime by recognition of endogenous self-antigens.
Central tolerance cannot by itself prevent responses feasible, such as accurate quantitation of rare antigen-
specific lymphocytes in vivo, their detection in tissueto self-antigens that are not present in the generative
lymphoid organs. Tolerance to these peripheral tissue sections, and real-time observation of cell±cell interac-
tions using fluorescent probes. Recent studies also sug-antigens is induced and maintained by several mecha-
nisms. In T cells, these mechanisms include functional gest that certain immune responses may generate pro-
tective or regulatory T cells that specifically shut offanergy, which results from recognition of self-antigens
Cell
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other responses. Understanding how to control and ma- wide range of immune-mediated diseases. It is this abil-
nipulate effector and regulatory lymphocytes is a central ity to overcome nature in the twenty-first century that
goal of immunology research. we look forward to.
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